BAFNA PHARMACEUTICALS
Back to All Ratios
|
BAFNA PHARMACEUTICALS Last 5 Year Profit After Tax (PAT) Margin History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| PAT Margin (%) | 7.37 | 2.85 | 4.82 | 9.83 | 6.13 |
What is the latest Profit After Tax (PAT) Margin ratio of BAFNA PHARMACEUTICALS ?
| Year | Profit After Tax (PAT) Margin |
|---|---|
| Mar2026 | 7.37 |
| Mar2025 | 2.85 |
| Mar2024 | 4.82 |
| Mar2023 | 9.83 |
| Mar2022 | 6.13 |
How is Profit After Tax (PAT) Margin of BAFNA PHARMACEUTICALS Trending?
| Years | Profit After Tax (PAT) Margin | % Change | |
|---|---|---|---|
| Mar2026 | 7.37 | 158.60 | |
| Mar2025 | 2.85 | -40.87 | |
| Mar2024 | 4.82 | -50.97 | |
| Mar2023 | 9.83 | 60.36 | |
| Mar2022 | 6.13 | - | |
Other Financial Ratios of BAFNA PHARMACEUTICALS
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Profit After Tax (PAT) Margin ratio of peers of BAFNA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAFNA PHARMACEUTICALS | ₹827.1 Cr | 8.2% | 32% | 235.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹444,597.0 Cr | -0.1% | -2.4% | 13.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹255,195.0 Cr | 2.7% | 12.9% | 54.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹187,712.0 Cr | 1.8% | 2.5% | 40.9% | Stock Analytics | |
| CIPLA | ₹113,423.0 Cr | 0.6% | -3.8% | -11.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,195.0 Cr | 3.3% | 1.3% | -7.6% | Stock Analytics | |
BAFNA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAFNA PHARMACEUTICALS | 8.2% |
32% |
235.8% |
| SENSEX | -1% |
-4.9% |
-11% |
You may also like the below Video Courses